Skip to main content
. Author manuscript; available in PMC: 2023 Aug 9.
Published in final edited form as: J Med Syst. 2020 Sep 8;44(10):185. doi: 10.1007/s10916-020-01603-9
Dose - Examples of non-errors.

Example Number Error category Medication Order CDS Rationale Clinical Rationale

1 Prior to admission PTA dose lamotrigine (800 mg total daily) PTA Patient taking more than max daily dose lamotrigine (700 mg total daily) PTA
2 Appropriate dose for indication Propofol 140 mg given for seizure Over set max single dose of 50 mg
3 Common off-label use Albuterol/Ipratropium inhaler ordered 6 puffs Q4H. Exceeds max daily dose of 12 puffs and max single dose of 3 puffs This is commonly used off-label in this amount.
4 Approximate weight-based dose Dalteparin 17,500 units ordered daily Exceeds max calculated weight-based dose (16,−340 units) This is an appropriate approximation given practical logistics of dosing (RN would be unable to give this precise amount)
5 Bedside procedure, correct dose documented: Triamcinolone 10 mg intradermal ordered for single dose of 10 mg Exceeds max single dose. Only 1 mg (as recommended for single dose), thus correct dose was documented as being given by MD for procedure.
6 Inappropriate alert (not max dose) Magnesium Gluconate 2 g PO ordered one time only. Exceeds max single dose (1 g) Above set max dose of 1 g but not an unsafe dose.
Dose - Examples of errors

Example Number Error category Medication Order CDS Rationale Clinical Rationale

7 Overdose by max dose Flurazepam 30–60 mg ordered daily at bedtime prn. Max single and max daily dose 30 mg.
8 Ordered without indication Rifampin 600 mg IV ordered Q12H Exceeded max daily dose of 1200 mg. However, no apparent indication for patient to be on Rifampin.
9 Order conflicts with admin instructions Ibuprofen 600 mg ordered Q4H prn. exceeds max daily dose of 3200 mg if given all available doses) Automated comments of order stated to not give more than 3200 mg; however, TDD per order is 3600 mg
10 Systems/Order set Diltiazem 0.25 mg/kg ordered Q4H prn. (daily dose 1.5 mg/kg exceeding max daily dose of 1.05 mg/kg) Ordered for arrhythmia per order set but patient without history of, or ongoing, arrhythmia.

Drug-drug Interaction - Examples of non-errors

Example Number Error category Medication Order CDS Rationale Clinical Rationale

1 Selected quinolones / class Ia & III antiarrhythmics Moxifloxacin, Amiodarone Tablet 200 mg increased risk for QT prolongation benefit > risk for many patients, can be safely monitored.
2 tramadol/MAOIS Linezolid, Tramadol Tablet 25 mg increased risk for serotonin syndrome Requires increased monitoring
3 simvastatin / diltiazem simvastatin (> 10 mg); lovastatin (> 20 mg) / diltiazem increased risk of statin myopathy frequently done in the community if risk for CVD elevated with increased monitoring.
4 anticoagulants / metronidazole; tinidazole Warfarin 12.5 mg Tablet, Metronidazole 500 mg increased INR Can be monitored and dose-adjusted
5 methotrexate / sulfonamides; trimethoprim Trimethoprim 160 mg/Sulfamethoxazole 800 mg Tablet 1 tablet, Methotrexate Tablet 10 mg methotrexate toxicity Patients should be monitored for pancytopenia and myelotoxicity
6 methadone oraloxycodone extended release tablet Methadone Tablet 10 mg, Oxycodone SR Tablet 30 mg increased CNS depression/ duplicate opiate therapy Best practice would be to administer one long acting opiate at a time, but this may be done safely with monitoring in specific clinical settings
7 naltrexone / opioid analgesics Naltrexone Tablet 50 mg, Morphine 1–4 mg antagonist and agonist co-administered frequently done in treatment of acute on chronic pain
Drug-drug Interaction - Examples of errors

Example Number Error category Medication Order CDS Rationale Clinical Rationale

8a heparin subq / enoxaparin Enoxaparin 120 mg, Heparin 5000 Units duplicate anticoagulant increased risk of bleeding with low likelihood of clinical benefit
8b heparins-dabigatran Dabigatran Capsule 150 mg, Heparin 5000 Units duplicate anticoagulant increased risk of bleeding with low likelihood of clinical benefit
9a cgmp specific pde type-5 inhibitors / nitrates Sildenafil Tablet 12.5 mg, Nitroglycerin Sublingual Tablet 0.4 mg hypotension, duplicate class SL NTG and PDE’s are OK if both are PRN and pt. is educated, but Long acting/ standing nitrates are not OK
with PDE’s: isosorbide mononitrate, transdermal patches, isosorbide mononitrate
9b gentamicin / tobramycin Gentamicin, Tobramycin duplicate class increased risk of toxicity. Duplicate class